These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 604107
1. Persistence of influenza A/New Jersey/76 (Hsw1N1) antibody one year after vaccination. Noble GR, Kaye HS, O'Brien RJ, Kendal AP, Bregman DJ, Wright PF, Amler RW, Dowdle WR. Dev Biol Stand; ; 39():253-60. PubMed ID: 604107 [Abstract] [Full Text] [Related]
2. Persistence of influenza serum antibodies in humans following immunization with a bivalent A/Victoria and A/New Jersey vaccine. Boucher DW, Contreras G, Furesz J. Can Med Assoc J; 1979 Apr 07; 120(7):799-802, 831. PubMed ID: 427686 [Abstract] [Full Text] [Related]
3. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA. Pediatrics; 2006 Sep 07; 118(3):e570-8. PubMed ID: 16950948 [Abstract] [Full Text] [Related]
4. HI antibody response in volunteers vaccinated with live influenza A/New Jersey/76 vaccine. Ikić D, Smerdel S, Manhalter T, Pasini N, Delimar N. Dev Biol Stand; 2006 Sep 07; 39():67-71. PubMed ID: 342319 [Abstract] [Full Text] [Related]
5. Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years. Nabeshima S, Kashiwagi K, Murata M, Kanamoto Y, Furusyo N, Hayashi J. J Med Virol; 2007 Mar 07; 79(3):320-5. PubMed ID: 17245715 [Abstract] [Full Text] [Related]
6. Vaccination of an adolescent group with A (H3N2) + A(HSW1N1) bivaccine before an A (H1N1) influenza epidemic. Stumpa A, Cihla F, Tůmová B, Husek V, Slezácek J. Acta Virol; 1979 Sep 07; 23(5):443-5. PubMed ID: 42307 [Abstract] [Full Text] [Related]
7. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees. Kilbourne ED, Cerini CP, Khan MW, Mitchell JW, Ogra PL. J Immunol; 1987 May 01; 138(9):3010-3. PubMed ID: 3571981 [Abstract] [Full Text] [Related]
8. Serological response to an adsorbed killed trivalent influenza vaccine (including A/New Jersey 8/76 antigen). Sarateanu D, Ehrengut W, Pressler K. Dev Biol Stand; 1987 May 01; 39():235-8. PubMed ID: 604102 [Abstract] [Full Text] [Related]
9. Specific antibody response after influenza immunization in systemic lupus erythematosus. Abu-Shakra M, Press J, Varsano N, Levy V, Mendelson E, Sukenik S, Buskila D. J Rheumatol; 2002 Dec 01; 29(12):2555-7. PubMed ID: 12465151 [Abstract] [Full Text] [Related]
10. Live tissue culture influenza vaccine for oral administration. I. Specific immune response to monovaccine A (H3N2) in volunteers. Alekseeva AK, Andzhaparidze OG, Gracheva EN, Sidorova LA, Melnikova SK. Acta Virol; 1979 Jan 01; 23(1):59-66. PubMed ID: 35960 [Abstract] [Full Text] [Related]
11. [Antibody response to hemagglutinin and neuraminidase induced by an influenza subunit vaccine (author's transl)]. Kuwert E, Werner J, Franke G, Paulus W. Zentralbl Bakteriol Orig A; 1979 Jun 01; 244(1):1-16. PubMed ID: 92113 [Abstract] [Full Text] [Related]
12. Persistence of antibody after the administration of influenza vaccine to children with cancer. Sumaya CV, Williams TE. Pediatrics; 1982 Feb 01; 69(2):226-9. PubMed ID: 7058098 [Abstract] [Full Text] [Related]
13. Potentiation of the immune response to influenza virus subunit vaccines. Webster RG, Glezen WP, Kasel JA, Laver WG. Dev Biol Stand; 1982 Feb 01; 39():243-8. PubMed ID: 604104 [Abstract] [Full Text] [Related]
14. Clinical trials with a new influenza subunit vaccine in adults and children. Kunz C, Hofmann H, Bachmayer H, Liehl E, Moritz AJ. Dev Biol Stand; 1982 Feb 01; 39():297-302. PubMed ID: 342311 [Abstract] [Full Text] [Related]
15. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children. Beutner KR, Rizzone C, DeMello S, Ogra PL. Dev Biol Stand; 1976 Feb 01; 33():162-70. PubMed ID: 782964 [Abstract] [Full Text] [Related]
16. Serological responses to whole and split A/New Jersey vaccines in humans and mice following priming infection with influenza A viruses. Ennis FA, Wise TG, McLaren C, Verbonitz MW. Dev Biol Stand; 1976 Feb 01; 39():261-6. PubMed ID: 604108 [Abstract] [Full Text] [Related]
17. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine]. Dong PM, Li YQ, Zheng TZ, Jia YP, Li F, Han TW, Qiao RX, Zhang BH. Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul 01; 24(7):570-3. PubMed ID: 12975010 [Abstract] [Full Text] [Related]
18. Augmentation of hemagglutination-inhibition (HI) antibodies in gilts of breeding age by large dosages of human A/New Jersey/76 influenza vaccine. Woods GT, Mansfield ME. Res Commun Chem Pathol Pharmacol; 1979 Feb 01; 23(2):399-402. PubMed ID: 461965 [Abstract] [Full Text] [Related]
19. Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination. Muhamed G, Greenbaum E, Zakay-Rones Z. Isr Med Assoc J; 2006 Mar 01; 8(3):155-8. PubMed ID: 16599048 [Abstract] [Full Text] [Related]
20. Clinical reactions and serologic responses after vaccination with whole-virus or split-virus influenza vaccines in children aged 6 to 36 months. Bernstein DI, Zahradnik JM, DeAngelis CJ, Cherry JD. Pediatrics; 1982 Apr 01; 69(4):404-8. PubMed ID: 7070886 [Abstract] [Full Text] [Related] Page: [Next] [New Search]